Spyre Therapeutics (SYRE) Q1 2021 Earnings

10MayExpected
Q2 2020
Q3 2020
Q4 2020
Q1 2021
-10
-6.74
-3.49
-0.23

Details

Expected EPS
-0.2286
Actual EPS
-7
Surprise EPS
-6.77
Surprise Percent
+2,962.12%

Description

Spyre Therapeutics (SYRE) has reported earnings of -7 per share for Q1 2021.

0 Comments

Share your thoughts